Mohammad Abu Sufian
Impact in
-
- Alzheimer's disease research and treatments
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 2
-
- Big Data and Business Intelligence 3
- Co-authors
- Md. Tanvir Kabir (4 shared papers)Md. Sahab Uddin (7 shared papers)Ghulam Md Ashraf (2 shared papers)Md. Shah Amran (2 shared papers)Mst. Marium Begum (2 shared papers)Shammi Akhter (1 shared paper)Md. Sahab Uddin (1 shared paper)Ariful Islam (1 shared paper)
- Journals
- Frontiers in Physiology (1 paper)Journal of Pharmacology and Toxicology (1 paper)Sustainable Development (1 paper)European Journal of Pharmacology (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- BangladeshUnited StatesEgypt
In The Last Decade
Mohammad Abu Sufian
16 papers receiving 279 citations
Peers
Comparison fields: 5 of 83
- Biological Psychiatry 11
- Physiology 100
- Pharmacology 64
- Complementary and alternative medicine 24
- Neurology 18
Countries citing papers authored by Mohammad Abu Sufian
This map shows the geographic impact of Mohammad Abu Sufian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abu Sufian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abu Sufian more than expected).
Fields of papers citing papers by Mohammad Abu Sufian
This network shows the impact of papers produced by Mohammad Abu Sufian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abu Sufian. The network helps show where Mohammad Abu Sufian may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Abu Sufian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 93 | |
| 2 | Ownership Structure and Corporate Social Responsibility Disclosure in Bangladesh | 2013 | 40 |
| 3 | 2017 | 37 | |
| 4 | 2022 | 27 | |
| 5 | 2021 | 18 | |
| 6 | 2021 | 15 | |
| 7 | 2017 | 15 | |
| 8 | 2017 | 14 | |
| 9 | 2017 | 11 | |
| 10 | 2017 | 7 | |
| 11 | 2024 | 4 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 3 | |
| 14 | 2016 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2020 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Mohammad Abu Sufian
Mohammad Abu Sufian is a scholar working on Pharmacology, Management Information Systems, Endocrinology, Diabetes and Metabolism, Plant Science and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 292 indexed citations. Recurring topics across this work include Big Data and Business Intelligence (3 papers), Natural Antidiabetic Agents Studies (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), melanin and skin pigmentation (2 papers), Impact of AI and Big Data on Business and Society (2 papers), Auditing, Earnings Management, Governance (2 papers), Dyeing and Modifying Textile Fibers (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Biological Psychiatry (11 citations), Physiology (100 citations), Pharmacology (64 citations), Complementary and alternative medicine (24 citations) and Neurology (18 citations). Mohammad Abu Sufian has collaborated with scholars based in Bangladesh, United States and Egypt. Frequent co-authors include Md. Tanvir Kabir, Md. Sahab Uddin, Ghulam Md Ashraf, Md. Shah Amran, Mst. Marium Begum, Shammi Akhter, Md. Sahab Uddin, Ariful Islam, Bijo Mathew and Md. Siddiqul Islam. Their work appears in journals such as Frontiers in Physiology, Journal of Pharmacology and Toxicology, Sustainable Development, European Journal of Pharmacology and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.